Industry: Chemical & Material
Published Date: 2025-02-21
Pages: 91 Pages
Report ld: 4157645
Request Sample
Customized Report
The global market for Amikacin Sulfate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Amikacin binds to the 30s subunit of the bacterial ribosome, preventing the read of the RNA, thus prevents the synthesis of necessary proteins for its growth and development.CAS number is 39831-55-5, and the molecular formula is c22h43n5o13.2 (H2SO4).
North American market for Amikacin Sulfate is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Amikacin Sulfate is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Amikacin Sulfate include Chengdu Brilliant Pharmaceutical Group, Chongqing Daxin Pharmaceutical, Interquim Mexico, CONBA Group, Suanfarma, HangZhou HuiSheng Biotech Pharmaceutical, Iffect Chemphar, Triveni Interchem, NC Pharm, Qilu Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Amikacin Sulfate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amikacin Sulfate.
The Amikacin Sulfate market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Amikacin Sulfate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amikacin Sulfate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Amikacin Sulfate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Amikacin Sulfate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Amikacin Sulfate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Amikacin Sulfate Market Overview
1.1 Product Definition
1.2 Amikacin Sulfate by Type
1.2.1 Global Amikacin Sulfate Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Purity≥98%
1.2.3 Purity≥99%
1.3 Amikacin Sulfate by Application
1.3.1 Global Amikacin Sulfate Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Amikacin Sulfate Injection
1.3.3 Other
1.4 Global Market Growth Prospects
1.4.1 Global Amikacin Sulfate Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Amikacin Sulfate Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Amikacin Sulfate Production Estimates and Forecasts (2020-2031)
1.4.4 Global Amikacin Sulfate Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Amikacin Sulfate Production Market Share by Manufacturers (2020-2025)
2.2 Global Amikacin Sulfate Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Amikacin Sulfate, Industry Ranking, 2023 VS 2024
2.4 Global Amikacin Sulfate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Amikacin Sulfate Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Amikacin Sulfate, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Amikacin Sulfate, Product Offered and Application
2.8 Global Key Manufacturers of Amikacin Sulfate, Date of Enter into This Industry
2.9 Amikacin Sulfate Market Competitive Situation and Trends
2.9.1 Amikacin Sulfate Market Concentration Rate
2.9.2 Global 5 and 10 Largest Amikacin Sulfate Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Amikacin Sulfate Production by Region
3.1 Global Amikacin Sulfate Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Amikacin Sulfate Production Value by Region (2020-2031)
3.2.1 Global Amikacin Sulfate Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Amikacin Sulfate by Region (2026-2031)
3.3 Global Amikacin Sulfate Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Amikacin Sulfate Production Volume by Region (2020-2031)
3.4.1 Global Amikacin Sulfate Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Amikacin Sulfate by Region (2026-2031)
3.5 Global Amikacin Sulfate Market Price Analysis by Region (2020-2025)
3.6 Global Amikacin Sulfate Production and Value, Year-over-Year Growth
3.6.1 North America Amikacin Sulfate Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Amikacin Sulfate Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Amikacin Sulfate Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Amikacin Sulfate Production Value Estimates and Forecasts (2020-2031)
4 Amikacin Sulfate Consumption by Region
4.1 Global Amikacin Sulfate Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Amikacin Sulfate Consumption by Region (2020-2031)
4.2.1 Global Amikacin Sulfate Consumption by Region (2020-2025)
4.2.2 Global Amikacin Sulfate Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Amikacin Sulfate Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Amikacin Sulfate Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Amikacin Sulfate Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Amikacin Sulfate Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Amikacin Sulfate Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Amikacin Sulfate Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Amikacin Sulfate Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Amikacin Sulfate Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Amikacin Sulfate Production by Type (2020-2031)
5.1.1 Global Amikacin Sulfate Production by Type (2020-2025)
5.1.2 Global Amikacin Sulfate Production by Type (2026-2031)
5.1.3 Global Amikacin Sulfate Production Market Share by Type (2020-2031)
5.2 Global Amikacin Sulfate Production Value by Type (2020-2031)
5.2.1 Global Amikacin Sulfate Production Value by Type (2020-2025)
5.2.2 Global Amikacin Sulfate Production Value by Type (2026-2031)
5.2.3 Global Amikacin Sulfate Production Value Market Share by Type (2020-2031)
5.3 Global Amikacin Sulfate Price by Type (2020-2031)
6 Segment by Application
6.1 Global Amikacin Sulfate Production by Application (2020-2031)
6.1.1 Global Amikacin Sulfate Production by Application (2020-2025)
6.1.2 Global Amikacin Sulfate Production by Application (2026-2031)
6.1.3 Global Amikacin Sulfate Production Market Share by Application (2020-2031)
6.2 Global Amikacin Sulfate Production Value by Application (2020-2031)
6.2.1 Global Amikacin Sulfate Production Value by Application (2020-2025)
6.2.2 Global Amikacin Sulfate Production Value by Application (2026-2031)
6.2.3 Global Amikacin Sulfate Production Value Market Share by Application (2020-2031)
6.3 Global Amikacin Sulfate Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Chengdu Brilliant Pharmaceutical Group
7.1.1 Chengdu Brilliant Pharmaceutical Group Amikacin Sulfate Company Information
7.1.2 Chengdu Brilliant Pharmaceutical Group Amikacin Sulfate Product Portfolio
7.1.3 Chengdu Brilliant Pharmaceutical Group Amikacin Sulfate Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Chengdu Brilliant Pharmaceutical Group Main Business and Markets Served
7.1.5 Chengdu Brilliant Pharmaceutical Group Recent Developments/Updates
7.2 Chongqing Daxin Pharmaceutical
7.2.1 Chongqing Daxin Pharmaceutical Amikacin Sulfate Company Information
7.2.2 Chongqing Daxin Pharmaceutical Amikacin Sulfate Product Portfolio
7.2.3 Chongqing Daxin Pharmaceutical Amikacin Sulfate Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Chongqing Daxin Pharmaceutical Main Business and Markets Served
7.2.5 Chongqing Daxin Pharmaceutical Recent Developments/Updates
7.3 Interquim Mexico
7.3.1 Interquim Mexico Amikacin Sulfate Company Information
7.3.2 Interquim Mexico Amikacin Sulfate Product Portfolio
7.3.3 Interquim Mexico Amikacin Sulfate Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Interquim Mexico Main Business and Markets Served
7.3.5 Interquim Mexico Recent Developments/Updates
7.4 CONBA Group
7.4.1 CONBA Group Amikacin Sulfate Company Information
7.4.2 CONBA Group Amikacin Sulfate Product Portfolio
7.4.3 CONBA Group Amikacin Sulfate Production, Value, Price and Gross Margin (2020-2025)
7.4.4 CONBA Group Main Business and Markets Served
7.4.5 CONBA Group Recent Developments/Updates
7.5 Suanfarma
7.5.1 Suanfarma Amikacin Sulfate Company Information
7.5.2 Suanfarma Amikacin Sulfate Product Portfolio
7.5.3 Suanfarma Amikacin Sulfate Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Suanfarma Main Business and Markets Served
7.5.5 Suanfarma Recent Developments/Updates
7.6 HangZhou HuiSheng Biotech Pharmaceutical
7.6.1 HangZhou HuiSheng Biotech Pharmaceutical Amikacin Sulfate Company Information
7.6.2 HangZhou HuiSheng Biotech Pharmaceutical Amikacin Sulfate Product Portfolio
7.6.3 HangZhou HuiSheng Biotech Pharmaceutical Amikacin Sulfate Production, Value, Price and Gross Margin (2020-2025)
7.6.4 HangZhou HuiSheng Biotech Pharmaceutical Main Business and Markets Served
7.6.5 HangZhou HuiSheng Biotech Pharmaceutical Recent Developments/Updates
7.7 Iffect Chemphar
7.7.1 Iffect Chemphar Amikacin Sulfate Company Information
7.7.2 Iffect Chemphar Amikacin Sulfate Product Portfolio
7.7.3 Iffect Chemphar Amikacin Sulfate Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Iffect Chemphar Main Business and Markets Served
7.7.5 Iffect Chemphar Recent Developments/Updates
7.8 Triveni Interchem
7.8.1 Triveni Interchem Amikacin Sulfate Company Information
7.8.2 Triveni Interchem Amikacin Sulfate Product Portfolio
7.8.3 Triveni Interchem Amikacin Sulfate Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Triveni Interchem Main Business and Markets Served
7.8.5 Triveni Interchem Recent Developments/Updates
7.9 NC Pharm
7.9.1 NC Pharm Amikacin Sulfate Company Information
7.9.2 NC Pharm Amikacin Sulfate Product Portfolio
7.9.3 NC Pharm Amikacin Sulfate Production, Value, Price and Gross Margin (2020-2025)
7.9.4 NC Pharm Main Business and Markets Served
7.9.5 NC Pharm Recent Developments/Updates
7.10 Qilu Pharmaceutical
7.10.1 Qilu Pharmaceutical Amikacin Sulfate Company Information
7.10.2 Qilu Pharmaceutical Amikacin Sulfate Product Portfolio
7.10.3 Qilu Pharmaceutical Amikacin Sulfate Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Qilu Pharmaceutical Main Business and Markets Served
7.10.5 Qilu Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Amikacin Sulfate Industry Chain Analysis
8.2 Amikacin Sulfate Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Amikacin Sulfate Production Mode & Process Analysis
8.4 Amikacin Sulfate Sales and Marketing
8.4.1 Amikacin Sulfate Sales Channels
8.4.2 Amikacin Sulfate Distributors
8.5 Amikacin Sulfate Customer Analysis
9 Amikacin Sulfate Market Dynamics
9.1 Amikacin Sulfate Industry Trends
9.2 Amikacin Sulfate Market Drivers
9.3 Amikacin Sulfate Market Challenges
9.4 Amikacin Sulfate Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Amikacin Sulfate was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-09
Pages: 135
USD 3950.00
(Single User License)
The global Amikacin Sulfate market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-25
Pages: 131
USD 2900.00
(Single User License)
The global Amikacin Sulfate market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-25
Pages: 137
USD 4900.00
(Single User License)
The global Amikacin Sulfate market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 79
USD 4250.00
(Single User License)
The global market for Amikacin Sulfate was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 101
USD 3950.00
(Single User License)
Amikacin binds to the 30s subunit of the bacterial ribosome, preventing the read of the RNA, thus prevents the synthesis of necessary proteins for its growth and development.CAS number is 39831-55-5, and the molecular formula is c22h43n5o13.2 (H2SO4).
Published Date: 2024-04-16
Pages: 114
USD 4900.00
(Single User License)
Amikacin binds to the 30s subunit of the bacterial ribosome, preventing the read of the RNA, thus prevents the synthesis of necessary proteins for its growth and development.CAS number is 39831-55-5, and the molecular formula is c22h43n5o13.2 (H2SO4).
Published Date: 2024-01-25
Pages: 117
USD 3950.00
(Single User License)
Amikacin binds to the 30s subunit of the bacterial ribosome, preventing the read of the RNA, thus prevents the synthesis of necessary proteins for its growth and development.CAS number is 39831-55-5, and the molecular formula is c22h43n5o13.2 (H2SO4).
Published Date: 2024-01-11
Pages: 95
USD 2900.00
(Single User License)
The global market for Amikacin Sulfate was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-09
Pages: 135
The global Amikacin Sulfate market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-25
Pages: 131
The global Amikacin Sulfate market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-25
Pages: 137
The global Amikacin Sulfate market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 79
The global market for Amikacin Sulfate was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 101
Amikacin binds to the 30s subunit of the bacterial ribosome, preventing the read of the RNA, thus prevents the synthesis of necessary proteins for its growth and development.CAS number is 39831-55-5, and the molecular formula is c22h43n5o13.2 (H2SO4).
Published: 2024-04-16
Pages: 114
Amikacin binds to the 30s subunit of the bacterial ribosome, preventing the read of the RNA, thus prevents the synthesis of necessary proteins for its growth and development.CAS number is 39831-55-5, and the molecular formula is c22h43n5o13.2 (H2SO4).
Published: 2024-01-25
Pages: 117
Amikacin binds to the 30s subunit of the bacterial ribosome, preventing the read of the RNA, thus prevents the synthesis of necessary proteins for its growth and development.CAS number is 39831-55-5, and the molecular formula is c22h43n5o13.2 (H2SO4).
Published: 2024-01-11
Pages: 95
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now